Letter From the President of LUGPA
LUGPA News
Corrected disclosure information
PROSTATE CANCER
The Data Behind a New mHSPC Indication for Darolutamide: A Review of the Phase 3 ARANOTE Study
Neal D. Shore, Alberto Martini, Pedro Barata
Food Effect of Abiraterone Acetate in Patients With Prostate Cancer Alexander Guminski, Christopher M. Pieczonka, Bryan A. Mehlhaff, Antonio Fojo, Anthony M. Joshua
An Open-Label, Single-Arm Study of the Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate Injectable Suspension in Patients With Prostate CancerGordon Brown, Raoul S. Concepcion, Celestia Higano, Bassem Elmankabadi, Ben Chien, Yisheng Lee, Yuhua Li, Andrew Guarino, William Miller, Jagdish Parasrampuria, Mathieu Boudreau, Martha Hernandez-Illas, Connor Peterson
BLADDER CANCER
Sasanlimab, an Emerging Immunotherapy for Non–Muscle-Invasive Bladder Cancer: A Review of the Phase 3 CREST TrialNeal D. Shore, Gary Steinberg
Review of UGN-102: A Reverse Thermal Gel Containing Mitomycin for the Treatment of Recurrent, Low-Grade, Intermediate-Risk Non–Muscle-Invasive Bladder Cancer Sandip M. Prasad, Mark Schoenberg, Michael J. Louie, Sunil Raju, Andrew Meads, Brent Burger, Victoria Tsurutis, Nikky Ugwuoke, Veronica Lee, John P. Sfakianos
BUSINESS OF UROLOGY
Building and Operating a Urologic Theranostics Center: A Practical GuideJeffrey Spier, Brian Nabhan, Hector Santana, Jameson Mendel
CODING CORNER
Development of a MIPS Value Pathway Reporting Option for Urology PaymentJacqlyn Riposo, David Blaisdell, Celeste Kirschner, Karen Johnson, Alan Kaplan, Gordon Brown, Franklin Gaylis, Courtney Morrow, Samuel Stolpe
CASE OF THE QUARTER
Germline Genetic Testing: A Case Study of a Patient With Prostate Cancer and a BRCA2 Mutation and Implications for the Family
Sherry Lynn Denton, Bernard Michael Gburek